Vancouver Psilocybin Gets Greenlight
Vancouver psilocybin gets the greenlight. A Canadian pharmaceutical company headquartered in Vancouver is set to conduct North America's inaugural at-home psilocybin clinical trial. Health Canada has given the green light for the second phase of Apex Labs' trial, focusing on assessing the safety and effectiveness of their low-dose, multi-dose product APEX-52 in addressing depression among veterans with post-traumatic stress disorder. Canada Green Lights Psilocybin On Oct. 24, Health Canada approved MDMA and psilocybin for the Special Access Program after nearly 11 months. These exemption enables healthcare professionals to use psilocybin on a case-by-case basis, recognizing potential patient benefits. A Wealth...